PolySonâ„¢ T
US agent for tumor imaging
PolySonâ„¢ T ultrasound contrast agent (1 x 5 injections): 130 - 095 - 148
PolySonâ„¢ T ultrasound contrast agent (5 x 5 injections): 130 - 095 - 149
Viscover’s innovative ultrasound agent PolySon T consists of microbubbles, which are optimized for imaging of tumors. The agent’s exceptionally high contrast enhancement coupled with its long blood half-life enables improved visualization of vascularized tumors in animal tumor models.
The innovative ultrasound agent, PolySon T:
- Is highly echogenic delivering optimal contrast at all typically used frequencies
- Has a long circulation time enabling a wide imaging time window
- Is suitable for the visualization of vascularized tumors
- PolySon T is Viscover’s leading US agent for tumor imaging
Apply PolySon T to:
- Detect tumors in animal tumor models
- Effectively monitor tumor progression
- Evaluate the efficacy of new therapies
1-3 µm
Schematic diagram of a PolySon T microbubble
Contrast-enhanced ultrasound (CEUS) image of the left liver lobe of an HBV-transgenic mouse showing hyperenhancement of a hepatocellular carcinoma (HCC) nodule (white arrow) at 6 s post injection of PolySon T.
- Marra, P. et al. (2016) SCharacterization of liver nodules with Gd-EOB-DTPA-enhanced MRI and contrast enhanced UltraSound (CEUS) in a transgenic mouse model of hepatocellular carcinoma. European Congress of Radiology, Vienna, Austria, C-1187.